Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Barrett Esophagus × Prednisolone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma 37 Prostatic Neoplasms 28 Precursor Cell Lymphoblastic Leukemia-Lymphoma 27 Lymphoma, Large B-Cell, Diffuse 25 Leukemia 14 Lymphoma, Follicular 13 Lymphoma, Non-Hodgkin 11 Hodgkin Disease 10 Burkitt Lymphoma 8 Neoplasm Metastasis 7 Leukemia, Biphenotypic, Acute 6 Recurrence 5 Lymphoma, B-Cell 5 Hemangioma 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Ovarian Neoplasms 4 Lymphoma, Large-Cell, Anaplastic 4 Immunoblastic Lymphadenopathy 4 Neoplasms 3 Multiple Myeloma 3 Lymphoma, Large-Cell, Immunoblastic 3 Dendritic Cell Sarcoma, Interdigitating 3 Breast Neoplasms 3 Neurotoxicity Syndromes 2 Neoplasm, Residual 2 Myasthenia Gravis 2 Metastatic Castration-resistant Prostate Cancer 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell 2 Lymphoma, Mantle-Cell 2

Interventions

Endoscopy 15 Endoscopy, Digestive System 12 Biopsy 9 Endoscopic Mucosal Resection 8 Radiofrequency Ablation 7 Esomeprazole 7 Specimen Handling 6 Gastroscopy 6 Omeprazole 4 Aspirin 4 Proflavine 3 Narrow Band Imaging 3 Diagnostic Imaging 3 Breath Tests 3 YF 476 2 Proton Pump Inhibitors 2 Photochemotherapy 2 Microscopy, Confocal 2 Metformin 2 Lansoprazole 2 Itraconazole 2 Endoscopes 2 Dexlansoprazole 2 Cryotherapy 2 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2 rofecoxib 1 polyphenon E 1 omeprazole, sodium bicarbonate drug combination 1 obeticholic acid 1 gluconic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02004782 2025-03-27

BERST

Western Sydney Local Health District

Phase 4 Withdrawn

Gastrointestinal

Barrett Esophagus, Esophageal Stenosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡